Policy on Secondary Publication

The Critical Patient Journal (RDC) recognizes that, in exceptional circumstances, the secondary publication of scientific papers can contribute to a greater dissemination of knowledge, as long as it is carried out in a transparent, ethical manner and in accordance with international recommendations.

Secondary publication consists of the republication in whole or in part of a previously published scientific work, addressed to a different audience or presented in another language, without this constituting undue duplicate publication.

The RDC may accept or authorize the secondary publication of a manuscript, provided that the following conditions are met, cumulatively:

        There is prior authorization from the editors of the publications involved, when applicable;

        The secondary publication is intended for an audience other than that of the original publication or corresponds to a translation intended to expand the dissemination of scientific knowledge;

        An appropriate time interval between the original publication and the secondary publication is respected, unless otherwise agreed between the parties;

        The scientific content faithfully reflects the data, results and conclusions of the original publication, and only editorial, linguistic or presentation adaptations may be made that do not alter its scientific significance;

        the secondary publication clearly identifies the full reference of the original publication and expressly indicates that it is a secondary publication, made with the permission of the parties involved;

        Applicable copyright, licensing conditions and ethical requirements are respected.

Authors must inform the Journal, at the time of submission, whenever the manuscript corresponds, in whole or in part, to a previous publication or is planned for secondary publication, providing all the necessary documentation for editorial appreciation.

The omission of this information may be considered redundant or duplicate undeclared publication and may be treated in accordance with the Journal's Scientific Misconduct Policy.

This policy does not apply to the dissemination of abstracts presented at scientific meetings, communications at congresses, preprints, theses, dissertations or other documents whose disclosure is compatible with the editorial policies of the Journal and duly declared by the authors.

This policy is aligned with the Recommendations for the Conduct, Reporting, Editing and Publication of Scholarly Work in Medical Journals of  the International Committee of Medical Journal Editors (ICMJE), with the guidelines of the Committee on Publication Ethics (COPE) and with international good practices in scientific publication.